Receptor Cross-Talk in Early Metastatic Dissemination
Receptor Cross-Talk in Early Metastatic Dissemination
批准号:
10355901
负责人:
Mary Sharon Stack
金额:
$21.95万
依托单位:
依托单位国家:
美国
项目类别:
财政年份:
2006
资助国家:
美国
项目状态:
已结题
起止时间:
2006-07-01 至 2024-01-31
关键词:
AbdomenAddressAdvanced Glycosylation End ProductsAgeAgingArchitectureAscitesBenchmarkingBiologicalBiological ModelsBiomechanicsBiosensing TechniquesCancer EtiologyCell AdhesionCell AgingCell CommunicationCessation of lifeCollagenCommunicationComplexCoupledCytolysisDataDiagnosisDiseaseDisease ProgressionDisseminated Malignant NeoplasmEvaluationEventFundingGoalsGrantGreater sac of peritoneumHumanIn VitroIncidenceInterventionIntra-abdominalKnock-outLaboratoriesLigandsLinkLiquid substanceMalignant Female Reproductive System NeoplasmMalignant NeoplasmsMalignant neoplasm of ovaryMediatingMediator of activation proteinMesothelial CellMetastatic toMicroRNAsMicrofluidicsMolecularMolecular AnalysisMusNeoplasm MetastasisOrphanPainPathway interactionsPatternPeritonealPeritoneal Mesothelial CellPeritoneal lavagePrognosisPropertyProtein-Lysine 6-OxidasePublishingQuantitative Reverse Transcriptase PCRROR1 geneReceptor Cross-TalkReceptor Protein-Tyrosine KinasesRegulationResearchRisk FactorsRoleStructureSurvival RateTechnologyTimeTissuesTumor BurdenValidationWomanage effectage relatedagedbasebiophysical propertiescancer cellcell behaviorcrosslinkepidemiologic dataexosomeexperimental studyimaging modalityimplantationin vivoin vivo ModelinnovationinsightintraperitonealmiRNA expression profilingmortalitynanoporeneoplastic cellnew technologynew therapeutic targetnovelnucleic acid detectionparent grantprogramsreceptorsolid statesuccesstumortumor microenvironment
中文摘要
点击翻译按钮获取中文摘要
英文摘要
ABSTRACT
Ovarian cancer (OvCa) is the most fatal gynecologic cancer with a low (<27%) 5-year survival rate. Survival of
women with OvCa has not changed appreciably in over 30 years and most women diagnosed will die of painful
complications that arise as a result of widely disseminated intraperitoneal (IP) metastasis. Epidemiologic data
indicate that age is a significant independent risk factor for OvCa incidence; however disease progression in
the aged host has not been examined experimentally. Experiments in the parent grant address the hypothesis
that host aging induces changes in peritoneal structure and function that influence tumor cell adhesion, matrix
anchoring, and ultimate metastatic success. Ongoing studies in Aim 1 examine age-induced changes in
peritoneal mesothelial cells (MCs) and the resulting impact on MC receptivity to metastatic implantation; Aim2
focuses on aging of the sub-MC collagen matrix, evaluation of aging-induced changes in matrix crosslinking
and biophysical properties, and the influence on metastatic anchoring; and Aim3 investigates Wnt5a as a
mediator of tumor:host cross-talk in the aging peritoneal cavity. In this ‘revision’ grant, we propose to add a
new aim to the parent grant to employ novel technology developed through support from the NCI Innovative
Molecular Analysis Technologies (IMAT) program. This research, conducted by Dr. H-C Chang, developed a
novel solid-state nanopore technology for isolation and lysis of exosomes from complex biofluids and capture
and quantitation of exosomal microRNAs. Using this technology, the new Aim 4 of the revision application will
assess the role of bi-directional tumor:host communication via exosome-mediated miRNA delivery in metastatic
progression in the context of host aging. Successful completion of the proposed experiments will provide
rigorous functional validation and benchmarking of the solid-state nanopore technology in an interesting and
relevant model system. Simultaneously we will enhance the impact of the parent grant and provide
unprecedented insight into molecules and events that mediate tumor:host communication in the aged host.
期刊论文(52)
专著(0)
科研奖励(0)
会议论文
登录
查看更多内容
DOI:
10.3390/cancers12113469
发表时间:
2020-11-21
期刊:
Cancers
影响因子:
5.2
作者:
[Yang J, Stack MS]
通讯作者:
Stack MS
DOI:
10.3390/cancers8090079
发表时间:
2016-08-26
期刊:
Cancers
影响因子:
5.2
作者:
[Asem MS, Buechler S, Wates RB, Miller DL, Stack MS]
通讯作者:
Stack MS
DOI:
10.1158/0008-5472.can-15-0706
发表时间:
2015-12-01
期刊:
Cancer research
影响因子:
11.2
作者:
[Liu Y, Metzinger MN, Lewellen KA, Cripps SN, Carey KD, Harper EI, Shi Z, Tarwater L, Grisoli A, Lee E, Slusarz A, Yang J, Loughran EA, Conley K, Johnson JJ, Klymenko Y, Bruney L, Liang Z, Dovichi NJ, Cheatham B, Leevy WM, Stack MS]
通讯作者:
Stack MS
DOI:
10.1158/1541-7786.mcr-17-0406
发表时间:
2018-08
期刊:
Molecular cancer research : MCR
影响因子:
--
作者:
[Tang J, Pulliam N, Özeş A, Buechlein A, Ding N, Keer H, Rusch D, O'Hagan H, Stack MS, Nephew KP]
通讯作者:
Nephew KP
DOI:
10.1016/j.bios.2014.04.008
发表时间:
2014-10-15
期刊:
BIOSENSORS & BIOELECTRONICS
影响因子:
12.6
作者:
[Senapati, Satyajyoti, Slouka, Zdenek, Shah, Sunny S., Behura, Susanta K., Shi, Zonggao, Stack, M. Sharon, Severson, David W., Chang, Hsueh-Chia]
通讯作者:
Chang, Hsueh-Chia
共 32 条
Receptor Cross-Talk in Early Metastatic Dissemination
-
批准号:10343706
-
项目类别:
-
资助金额:$32.36万
-
财政年份:2006
-
负责人:Mary Sharon Stack
-
依托单位:
Receptor Cross-Talk in Early Metastatic Dissemination
-
批准号:8104700
-
项目类别:
-
资助金额:$29.68万
-
财政年份:2006
-
负责人:Mary Sharon Stack
-
依托单位:
Receptor Cross-Talk in Early Metastatic Dissemination
-
批准号:7478538
-
项目类别:
-
资助金额:$24.4万
-
财政年份:2006
-
负责人:Mary Sharon Stack
-
依托单位:
Receptor Cross-Talk in Early Metastatic Dissemination
-
批准号:7254916
-
项目类别:
-
资助金额:$25.64万
-
财政年份:2006
-
负责人:Mary Sharon Stack
-
依托单位:
Receptor Cross-Talk in Early Metastatic Dissemination
-
批准号:7634470
-
项目类别:
-
资助金额:$24.35万
-
财政年份:2006
-
负责人:Mary Sharon Stack
-
依托单位:
Receptor Cross-Talk in Early Metastatic Dissemination
-
批准号:8257903
-
项目类别:
-
资助金额:$28.02万
-
财政年份:2006
-
负责人:Mary Sharon Stack
-
依托单位:
Receptor Cross-Talk in Early Metastatic Dissemination
-
批准号:8680171
-
项目类别:
-
资助金额:$28.91万
-
财政年份:2006
-
负责人:Mary Sharon Stack
-
依托单位:
Receptor Cross-Talk in Early Metastatic Dissemination
-
批准号:8391939
-
项目类别:
-
资助金额:$29.8万
-
财政年份:2006
-
负责人:Mary Sharon Stack
-
依托单位:
Receptor Cross-Talk in Early Metastatic Dissemination
-
批准号:10090457
-
项目类别:
-
资助金额:$33.02万
-
财政年份:2006
-
负责人:Mary Sharon Stack
-
依托单位:
Receptor Cross-Talk in Early Metastatic Dissemination
-
批准号:7149896
-
项目类别:
-
资助金额:$27.99万
-
财政年份:2006
-
负责人:Mary Sharon Stack
-
依托单位:
Cell Adhesion and Proteolytic Potential in OSCC
-
批准号:6863750
-
项目类别:
-
资助金额:$17.64万
-
财政年份:2004
-
负责人:Mary Sharon Stack
-
依托单位:
Cell Adhesion and Proteolytic Potential in OSCC
-
批准号:6713308
-
项目类别:
-
资助金额:$17.12万
-
财政年份:2003
-
负责人:Mary Sharon Stack
-
依托单位:
Interaction of uPA/R and Integrins in Oral Cancer
-
批准号:6748416
-
项目类别:
-
资助金额:$23.15万
-
财政年份:2001
-
负责人:Mary Sharon Stack
-
依托单位:
Interaction of uPA/R and Integrins in Oral Cancer
-
批准号:8391915
-
项目类别:
-
资助金额:$7.26万
-
财政年份:2001
-
负责人:Mary Sharon Stack
-
依托单位:
Interaction of uPA/R and Integrins in Oral Cancer
-
批准号:7763903
-
项目类别:
-
资助金额:$15.14万
-
财政年份:2001
-
负责人:Mary Sharon Stack
-
依托单位:
Interaction of uPA/R and Integrins in Oral Cancer
-
批准号:6633690
-
项目类别:
-
资助金额:$23.15万
-
财政年份:2001
-
负责人:Mary Sharon Stack
-
依托单位:
Interaction of uPA/R and Integrins in Oral Cancer
-
批准号:6370838
-
项目类别:
-
资助金额:$23.15万
-
财政年份:2001
-
负责人:Mary Sharon Stack
-
依托单位:
Interaction of uPA/R and Integrins in Oral Cancer
-
批准号:6514466
-
项目类别:
-
资助金额:$23.15万
-
财政年份:2001
-
负责人:Mary Sharon Stack
-
依托单位:
Interaction of uPAR & Integrins in Oral Cancer
-
批准号:7214619
-
项目类别:
-
资助金额:$22.41万
-
财政年份:2001
-
负责人:Mary Sharon Stack
-
依托单位:
Interaction of uPA/R and Integrins in Oral Cancer
-
批准号:7631264
-
项目类别:
-
资助金额:$22.41万
-
财政年份:2001
-
负责人:Mary Sharon Stack
-
依托单位:
海外基金